Speaker Profile

___	__
	Biography Dr. Emmanuel Bujold is a full professor at the Department of Obstetrics & Gynaecology of Laval University's School of Medicine where he holds the Jeanne et Jean-Louis Lévesque Research Chair in Perinatology. He completed his medical studies and his residency in obstetrics/gynaecology at the University of Montreal, Quebec, Canada, his fellowship in maternal fetal medicine at Wayne State University, Michigan, USA, and a Masters in epidemiology at Laval University, Quebec Canada. His research centers on vaginal birth after cesarean, uterine rupture, preterm labor and delivery, as well as the prediction and prevention of preeclampsia and IUGR. Leading several large Canadian pregnancy cohorts and one of the largest Canadian Pregnancy Research Units focused on the discovery and validation of pregnancy outcome markers, Dr. Bujold has authored more than 800 scientific communications and more than 300 peer-reviewed articles. Disclosure 1. I do not have a relationship with a for-profit and/or a not-for-profit organization to disclose. 2. I do not intend to make therapeutic recommendations for medications that have not received regulatory approval (i.e. “off-label” use of medication).

Biography
Dr. Emmanuel Bujold is a full professor at the Department of Obstetrics & Gynaecology of Laval University's School of Medicine where he holds the Jeanne et Jean-Louis Lévesque Research Chair in Perinatology. He completed his medical studies and his residency in obstetrics/gynaecology at the University of Montreal, Quebec, Canada, his fellowship in maternal fetal medicine at Wayne State University, Michigan, USA, and a Masters in epidemiology at Laval University, Quebec Canada. His research centers on vaginal birth after cesarean, uterine rupture, preterm labor and delivery, as well as the prediction and prevention of preeclampsia and IUGR. Leading several large Canadian pregnancy cohorts and one of the largest Canadian Pregnancy Research Units focused on the discovery and validation of pregnancy outcome markers, Dr. Bujold has authored more than 800 scientific communications and more than 300 peer-reviewed articles.
Disclosure
1. I do not have a relationship with a for-profit and/or a not-for-profit organization to disclose. 2. I do not intend to make therapeutic recommendations for medications that have not received regulatory approval (i.e. “off-label” use of medication).